Telomerase activity in hepatocellular carcinoma and adjacent liver tissues

Journal of Surgical Oncology

Volumn 69, Issue 3, 1998, Pages 119-124

  Kishimoto, Keigo ^a   Fujimoto, Jiro ^a   Takeuchi, Masaharu ^a   Yamamoto, Hidenao ^a   Ueki, Takahiro ^a   Okamoto, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis; Hepatocellular carcinoma; Leukocytes; Liver cirrhosis; Telomerase

Indexed keywords

CD15 ANTIGEN; CD45 ANTIGEN; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0031796479     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199811)69:3<119::AID-JSO1>3.0.CO;2-Q     Document Type: Article

References (35)

1. DiBisceglie AM, Rustgi VK, Hoofnagle JH, et al.: Hepatocellular carcinoma. Ann Intern Med 1988;108:390-401.
2. Bosch FX, Munoz N: Hepatocellular carcinoma in the world: Epidemiologic questions. In Tabor E, DiBisceglie AM, Purcell RH (eds): "Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America." Houston: Gulf Publishing Company, 1991:35-54.
3. Takuma H, Hiyama T, Tanaka S, et al.: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
4. Saito I, Miyamura T, Ohbayashi A, et al.: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547-6549.
5. Vogelstein B, Fearon ER, Hamilton SR, et al.: Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319: 525-532.
6. Bos JL: ras oncogene in human cancer: A review. Cancer Res 1989;49:4682-4689.
7. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991;253:49-53.
8. Slagle BL, Lee TH, Butel JS: Hepatitis B virus and hepatocellular carcinoma. Prog Med Virol 1992;39:167-203.
9. Unsal H, Yakicier C, Marcais C, et al.: Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci USA 1994;91:822-826.
10. Blackburn EH: The molecular structure of centromeres and telomeres. Annu Rev Biochem 1984;53:163-194.
11. Blackburn EH: Structure and function of telomeres. Nature 1991; 350:569-573.
12. Zakian VA: Telomeres: beginning to understand the end. Science 1995;270:1601-1607.
13. Allsopp RC, Vaziri H, Patterson C, et al.: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-10118.
14. Hastie ND, Dempster M, Dunlop MG, et al.: Telomere reduction in human colorectal carcinoma and with aging. Nature 1990;346: 866-871.
15. Harley CB, Futcher AB, Greider CW: Telomeres shorten during aging of human fibroblasts. Nature 1990;345:458-460.
16. Harley CB: Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 1991;256:271-282.
17. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59:521-529.
18. Kim MW, Piatyszek MA, Prowse KR, et al.: Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
19. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-791.
20. Tahara H, Nakanishi T, Kitamoto M, et al.: Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-2736.
21. Nouso K, Urabe Y, Higashi T, et al.: Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996;78:232-236.
22. Kojima H, Yokosuka O, Imazeki F, et al.: Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997;112:493-500.
23. Counter CM, Gupta J, Harley CB, et al.: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85:2315-2320.
24. Broccoli D, Young JW, de Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995;92:9082-9086.
25. Hiyama K, Hirai Y, Kyoizumi S, et al.: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-3715.
26. Liver Cancer Study Group of Japan: "The General Rules for the Clinical and Pathological Study of Primary Liver Cancer." 3rd Ed. Kyoto: Kanehara. 1992:25-35.
27. Nakabayashi H, Taketa K, Yamane T, et al.: Phenotypical stability of a human hepatoma cell line, HuH7, in long-term culture with chemically defined medium. Jpn J Cancer Res (Gann) 1984;75: 151-158.
28. Piatyszek MA, Kim NW, Weinrich SL, et al.: Detection of telomerase activity in human cells and tumors by telomeric amplification protocol (TRAP). Methods Cell Sci 1995;17:1-15.
29. Wright WE, Shay JW, Piatyszek MA: Modification of telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-3795.
30. Cobbold S, Hale G, Waldmann H: Non-lineage. LFA-1 family, and leucocyte common antigens: new and previously defined clusters. In McMichael AJ (eds): "Leucocyte typing." Vol III. Oxford: Oxford University Press, 1987:788-803.
31. Thomas ML: The leukocyte common antigen family. Annu Rev Immunol 1989;7:339-369.
32. Manyonda IT, Soltys AJ, Hay FK: A critical evaluation of the magnetic cell sorter and its use in the positive and negative selection of CD45RO* cells. J Immunol Methods 1992;149:1-10.
33. Bettelheim PM: Cluster report: CD15. In Knapp W (ed): "Leukocyte Typing." Vol IV. Oxford: Oxford University Press, 1989: 798-799.
34. Nakayama J, Saito M, Nakamura H, et al.: TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 1997;88:875-884.
35. Bryan TM, Englezou A, Gupta J, et al.: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;14:4240-4248.